Veterinary Medicines

T 61

Authorised
  • Embutramide
  • Tetracaine
  • Mebezonium
Download as PDF

Product identification

Medicine name:
T 61
Active substance:
  • Embutramide
  • Tetracaine
  • Mebezonium
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Cat
  • Equid
  • Sheep
  • Goat
  • Dog
  • Poultry
Route of administration:
  • Intracardiac use
  • Intrapulmonary use
  • Intravenous use

Product details

Active substance and strength:
  • Embutramide
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tetracaine
    4.39
    milligram(s)
    /
    1.00
    millilitre(s)
  • Mebezonium
    26.92
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intracardiac use
    • Cattle
    • Pig
    • Rabbit
    • Cat
    • Equid
    • Sheep
    • Goat
    • Dog
    • Poultry
  • Intrapulmonary use
    • Cattle
    • Pig
    • Rabbit
    • Cat
    • Equid
    • Sheep
    • Goat
    • Dog
    • Poultry
  • Intravenous use
    • Cattle
    • Pig
    • Rabbit
    • Cat
    • Equid
    • Sheep
    • Goat
    • Dog
    • Poultry
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AX50
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/8244456 5/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."